Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.

Little MH, Reitmeir P, Peters A, Leidl R.

Value Health. 2014 Jun;17(4):364-71. doi: 10.1016/j.jval.2014.02.002. Epub 2014 Apr 19.

2.

Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.

Kiadaliri AA, Eliasson B, Gerdtham UG.

Health Qual Life Outcomes. 2015 Sep 15;13:145. doi: 10.1186/s12955-015-0344-z.

3.

A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.

Couzner L, Crotty M, Norman R, Ratcliffe J.

Appl Health Econ Health Policy. 2013 Aug;11(4):415-25. doi: 10.1007/s40258-013-0039-8.

PMID:
23807538
4.

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L, Rowen D, Tsuchiya A.

Health Technol Assess. 2014 Feb;18(12):vii-xxvi, 1-191. doi: 10.3310/hta18120.

5.

[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].

Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ.

Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. Dutch.

PMID:
16038162
6.

Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population.

Gandhi M, Thumboo J, Luo N, Wee HL, Cheung YB.

Health Qual Life Outcomes. 2015 Jan 23;13:8. doi: 10.1186/s12955-014-0200-6.

7.

Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?

Feng Y, Devlin N, Herdman M.

Health Qual Life Outcomes. 2015 Oct 21;13:171. doi: 10.1186/s12955-015-0356-8.

8.

The social tariff of EQ-5D is not adequate to assess quality of life in patients with low back pain.

Zamora J, Kovacs F, Abraira V, Fernández C, Lázaro P; Spanish Back Pain Research Network..

Qual Life Res. 2007 Apr;16(3):523-31. Epub 2006 Nov 17.

PMID:
17111230
9.

A shortcut to mean-based time tradeoff tariffs for the EQ-5D?

Rand-Hendriksen K, Augestad LA, Dahl FA, Kristiansen IS, Stavem K.

Med Decis Making. 2012 Jul-Aug;32(4):569-77. doi: 10.1177/0272989X11431607. Epub 2012 Jan 12.

PMID:
22247424
10.

EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.

Kularatna S, Whitty JA, Johnson NW, Jayasinghe R, Scuffham PA.

PLoS One. 2014 Nov 3;9(11):e108434. doi: 10.1371/journal.pone.0108434. eCollection 2014.

11.

Patient versus general population health state valuations: a case study of non-specific low back pain.

van Dongen JM, van denBerg B, Bekkering GE, van Tulder MW, Ostelo RWJG.

Qual Life Res. 2017 Jun;26(6):1627-1633. doi: 10.1007/s11136-017-1497-5. Epub 2017 Feb 2.

12.

Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.

König HH, Roick C, Angermeyer MC.

Eur Psychiatry. 2007 Apr;22(3):177-87. Epub 2006 Dec 4.

PMID:
17142014
13.

Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.

Bernert S, Fernández A, Haro JM, König HH, Alonso J, Vilagut G, Sevilla-Dedieu C, de Graaf R, Matschinger H, Heider D, Angermeyer MC; ESEMeD/MHEDEA 2000 Investigators..

Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.

14.
15.

Assessing quality of life in a clinical study on heart rehabilitation patients: how well do value sets based on given or experienced health states reflect patients' valuations?

Leidl R, Schweikert B, Hahmann H, Steinacker JM, Reitmeir P.

Health Qual Life Outcomes. 2016 Mar 22;14:48. doi: 10.1186/s12955-016-0453-3.

16.

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.

Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J.

Qual Life Res. 2013 Sep;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. Epub 2012 Nov 25.

17.

A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample.

Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G.

Clinicoecon Outcomes Res. 2016 Jun 13;8:267-74. doi: 10.2147/CEOR.S98226. eCollection 2016.

18.

Quality-of-life valuations of advanced breast cancer by New Zealand women.

Milne RJ, Heaton-Brown KH, Hansen P, Thomas D, Harvey V, Cubitt A.

Pharmacoeconomics. 2006;24(3):281-92.

PMID:
16519549
19.

Comparison of FACT- and EQ-5D-based utility scores in cancer.

Pickard AS, Ray S, Ganguli A, Cella D.

Value Health. 2012 Mar-Apr;15(2):305-11. doi: 10.1016/j.jval.2011.11.029. Epub 2012 Feb 2.

20.

Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China.

Sun S, Chen J, Kind P, Xu L, Zhang Y, Burström K.

Qual Life Res. 2015 Mar;24(3):693-703. doi: 10.1007/s11136-014-0793-6. Epub 2014 Sep 24.

Supplemental Content

Support Center